What's new? Log in Free sign up

Filing search / VBI Vaccines Inc / "Reimbursement"

Search information

VBI Vaccines Inc

Companies

"Reimbursement"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

69 results

Newest first Best match first

VBIVQ VBI Vaccines Inc

VBI Vaccines Reports First Quarter 2024 Financial Results

of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits

VBIVQ VBI Vaccines Inc

Quarterly report

sharing arrangement, reimbursement arrangement or other benefit, relief or privilege, from the government of the State of Israel or any other Governmental

15 May 24

4:01pm

VBIVQ VBI Vaccines Inc

Definitive proxy

, 2023 for services provided as a director except reimbursement of ordinary and reasonable expenses incurred in exercising their responsibilities … , then such officer shall be entitled to payments of their respective base salary and properly documented expense reimbursement that had accrued but had not been

29 Apr 24

4:05pm

VBIVQ VBI Vaccines Inc

consistent with applicable law including, but not limited to, (a) seeking reimbursement of all or part of Erroneously Awarded Compensation previously

16 Apr 24

8:01am

VBIVQ VBI Vaccines Inc

, Pricing and Reimbursement The commercial success of any biopharmaceutical products approved by the FDA depends in significant part on the availability … of third-party coverage and adequate reimbursement for the products. In the U.S., third-party payors include government healthcare programs

16 Apr 24

8:01am

5z3 oang8aizl56o8dyh

VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Quarterly report

14 Nov 23

4:06pm

Quarterly report

14 Nov 23

4:06pm

Quarterly report

14 Nov 23

4:06pm

VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants

rjyjb9pvlzigqvke31

Definitive proxy

1 May 23

4:05pm

VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split

Quarterly report

10 Nov 22

8:00am

VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures

npbxdwg38wb ke0ex

Shelf registration

26 Aug 22

4:55pm

w8ypvw jtyma0macw

VBI Vaccines Reports First Quarter 2022 Financial Results and Provides Corporate Update

Definitive proxy

29 Apr 22

4:51pm

Preliminary proxy

18 Apr 22

4:45pm

3i3hg0y07q9kl7m7jtzo

VBI Vaccines Announces PreHevbrio™ is Now Available in the United States for the Prevention of Hepatitis B in Adults

9pdwfy 1nfjqxd2y

7 Mar 22

8:01am

Prev
1
2
3
4
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.